1. Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study. (June 2021) Authors: Yang, Mengyuan; Li, Dan; Jiang, Wu; Zhu, Lizhen; Ju, Haixing; Sun, Yan; Shan, Yuqiang; Yang, Chunkang; Dong, Jian; Wang, Lin; Wu, Baoping; Qiu, Meng; Yin, Xianli; Wang, Xicheng; Xiong, Bin; Yan, Wei; Liu, Tao; Liu, Chenglin; Mao, Xinru; Ding, Kefeng Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Direct simulations of the linear elastic displacements field based on a lattice Boltzmann model. (8th December 2015) Authors: Yin, Xianli; Yan, Guangwu; Li, Tingting Journal: International journal for numerical methods in engineering Issue: Volume 107:Number 3(2016) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma. (May 2021) Authors: Liu, Dan; Ma, Chunguang; Lu, Ping; Gong, Jifang; Ye, Dingwei; Wang, Siyang; Peng, Peijian; Bai, Yuxian; Song, Yuqin; Chen, Jianhua; Jiang, Ou; Zhang, Guojun; Ba, Yi; Chen, Li; Pan, Jianji; Li, Qi; Zhang, Liling; Gu, Shanzhi; Yin, Xianli; Cao, Bangwei Journal: European journal of cancer Issue: Volume 148(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial. (December 2021) Authors: Xu, Rui-Hua; Zhang, Yanqiao; Pan, Hongming; Feng, Jifeng; Zhang, Tao; Liu, Tianshu; Qin, Yanru; Qin, Shukui; Yin, Xianli; Liu, Baorui; Ba, Yi; Yang, Nong; Voon, Pei Jye; Tanasanvimon, Suebpong; Zhou, Chan; Zhang, Wan Li; Shen, Lin Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 12(2021) Page Start: 1015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗